1. Home
  2. SATL vs MDXG Comparison

SATL vs MDXG Comparison

Compare SATL & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Satellogic Inc.

SATL

Satellogic Inc.

HOLD

Current Price

$6.78

Market Cap

968.5M

Sector

Technology

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$3.35

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SATL
MDXG
Founded
2010
2006
Country
United States
United States
Employees
154
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
968.5M
1.0B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
SATL
MDXG
Price
$6.78
$3.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$5.50
$9.00
AVG Volume (30 Days)
14.0M
1.4M
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
0.32
Revenue
N/A
$418,630,000.00
Revenue This Year
$88.89
N/A
Revenue Next Year
$56.98
$13.02
P/E Ratio
N/A
$10.33
Revenue Growth
N/A
19.99
52 Week Low
$1.26
$3.19
52 Week High
$8.35
$7.99

Technical Indicators

Market Signals
Indicator
SATL
MDXG
Relative Strength Index (RSI) 57.33 26.75
Support Level $6.49 N/A
Resistance Level $6.84 $7.39
Average True Range (ATR) 0.87 0.20
MACD -0.13 -0.03
Stochastic Oscillator 18.22 16.95

Price Performance

Historical Comparison
SATL
MDXG

About SATL Satellogic Inc.

Satellogic Inc is a vertically integrated Earth observation company that designs, manufactures, and operates satellite systems, delivering decision-grade insights at scale to government and commercial customers. Through an end-to-end production and operations model, it provides governments with flexible options across their journey toward sovereign Earth observation. From access to high-frequency imagery and managed space systems to full satellite ownership, to supporting autonomous data availability and long-term technological independence. It has monitoring and alert-driven workflows that help defense and intelligence agencies, civil governments, and commercial operators transition from reactive tasking to proactive decision-making, providing mission-critical data when needed.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: